Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19

Author(s): Shadma Wahab, Irfan Ahmad, Safia Irfan, Mohammad H. Baig, Abd-ElAziem Farouk and Jae-June Dong*

Volume 27, Issue 9, 2021

Published on: 01 January, 2021

Page: [1144 - 1152] Pages: 9

DOI: 10.2174/1381612826666210101154118

Price: $65

Abstract

The current 2019-nCoV outbreak is becoming extremely harmful and has affected the whole world. Its control is challenging because there is no effective vaccine or drug available for coronavirus disease. The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), previously named as 2019 novel coronavirus (2019-nCoV), primarily targets the human respiratory system to lung lesions and lethal pneumonia. Natural products have always shown a crucial role in the process of drug development against various diseases. They may serve as leads for further drug development to combat emergent mutants of the coronavirus. In this review, the current status of natural compounds and their derivatives acting against different species of CoV are discussed.

Keywords: Antivirals, COVID19, dietary supplements, natural products, phytotherapy, SARS-CoV-2.

« Previous Next »
[1]
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382(8): 727-33.
[http://dx.doi.org/10.1056/NEJMoa2001017] [PMID: 31978945]
[2]
To KKW, Tsang OTY, Yip CCY, et al. Consistent Detection of 2019 Novel Coronavirus in Saliva. Clin Infect Dis 2020; 71(15): 841-3.
[http://dx.doi.org/10.1093/cid/ciaa149] [PMID: 32047895]
[3]
Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 2020; 92(4): 441-7.
[http://dx.doi.org/10.1002/jmv.25689] [PMID: 31994742]
[4]
Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019-nCoV) Coronavirus. Am J Respir Crit Care Med 2020; 201(4): 7-P8.
[http://dx.doi.org/10.1164/rccm.2014P7] [PMID: 32004066]
[5]
Yang Y, Peng F, Wang R, et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun 2020.109102434
[http://dx.doi.org/10.1016/j.jaut.2020.102434] [PMID: 32143990]
[6]
Paules C, Marston H, Jama AF. undefined. Coronavirus infections-more than just the common cold. JamanetworkCom nd 2020.[7] Modes of transmission of virus causing COVID-19: implicationsfor IPC precaution recommendations. Available at:.
[7]
https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations
[8]
Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China: Elsevier 2019.
[9]
Soy M, Keser G, Atagündüz P. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Springer 2020.
[10]
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020.109102433
[http://dx.doi.org/10.1016/j.jaut.2020.102433] [PMID: 32113704]
[11]
Sarzi-Puttini P, Giorgi V. , Sirotti et al. Review COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?2020.
[12]
Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med 2020; 18(2): 152-8.
[http://dx.doi.org/10.1016/j.joim.2020.02.005] [PMID: 32113846]
[13]
Islam MT, Sarkar C, El-Kersh DM, et al. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phyther Res 2020.
[14]
Williamson EM, Liu X, Izzo AA. Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals. Br J Pharmacol 2020; 177(6): 1227-40.
[http://dx.doi.org/10.1111/bph.14943] [PMID: 31799702]
[15]
Akindele AJ, Agunbiade FO, Sofidiya MO, et al. .COVID-19 Pandemic: A Case for Phytomedicines. Nat Prod Commun 2020; 15: 1934578X2094508..
[16]
Lin L, Hsu W. medicine CL traditional and complementary In: undefined Antiviral natural products and herbal medicines. Elsevier n.d.2014.
[17]
Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol 2020; 92(7): 797-806.
[http://dx.doi.org/10.1002/jmv.25783] [PMID: 32198776]
[18]
Luo H, Tang QL, Shang YX, et al. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs. Chin J Integr Med 2020; 26(4): 243-50.
[http://dx.doi.org/10.1007/s11655-020-3192-6] [PMID: 32065348]
[19]
Yang Y, Islam M, Wang J. YL-I journal of undefined. In: Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. NcbiNlmNihGov n.d.2020.
[20]
Runfeng L, Yunlong H, Jicheng H, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacol Res 2020.156104761
[http://dx.doi.org/10.1016/j.phrs.2020.104761] [PMID: 32205232]
[21]
Coppola M, Mondola R. Phytotherapeutics and SARS-CoV-2 infection: Potential role of bioflavonoids. Med Hypotheses 2020.140109766
[http://dx.doi.org/10.1016/j.mehy.2020.109766] [PMID: 32353741]
[22]
Block KI, Mead MN. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2003; 2(3): 247-67.
[http://dx.doi.org/10.1177/1534735403256419] [PMID: 15035888]
[23]
Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 2020; 19(3): 149-50.
[http://dx.doi.org/10.1038/d41573-020-00016-0] [PMID: 32127666]
[24]
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020; 14(1): 72-3.
[http://dx.doi.org/10.5582/bst.2020.01047] [PMID: 32074550]
[25]
Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020; 56(1)105949
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105949] [PMID: 32205204]
[26]
Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa MG. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Int J Antimicrob Agents 2020; 56(2)106028
[http://dx.doi.org/10.1016/j.ijantimicag.2020.106028] [PMID: 32450198]
[27]
Schluenz LA, Ramos-Otero GP, Nawarskas JJ. Chloroquine or Hydroxychloroquine for Management of Coronavirus Disease 2019: Friend or Foe? Cardiol Rev 2020; 28(5): 266-71.
[http://dx.doi.org/10.1097/CRD.0000000000000329] [PMID: 32769401]
[28]
Redeploying plant defences. Nat Plants 2020; 6(177)
[http://dx.doi.org/10.1038/s41477-020-0628-0] [PMID: 32170291]
[29]
Hoever G, Baltina L, Michaelis M, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem 2005; 48(4): 1256-9.
[http://dx.doi.org/10.1021/jm0493008] [PMID: 15715493]
[30]
Zhang D, Zhang B, Lv JT, Sa RN, Zhang XM, Lin ZJ. The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence. Pharmacol Res 2020; 157..
[31]
Ho LTF, Chan KKH, Chung VCH, Leung TH. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19. Eur J Integr Med 2020.36101116
[http://dx.doi.org/10.1016/j.eujim.2020.101116] [PMID: 32292529]
[32]
Roy K, Kar S. Other Related Techniques Underst Basics QSAR Appl Pharm Sci Risk Assess. Elsevier 2015; pp. 357-425.
[33]
Wang SQ, Du QS, Zhao K, Li AX, Wei DQ, Chou KC. Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. Amino Acids 2007; 33(1): 129-35.
[http://dx.doi.org/10.1007/s00726-006-0403-1] [PMID: 16998715]
[34]
Joshi T, Joshi T, Sharma P. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking nd
[35]
Adem S, Eyupoglu V, Sarfraz I, Rasul A, Ali M. Identification of Potent COVID-19 Main Protease (Mpro) Inhibitors from Natural Polyphenols: An in Silico Strategy Unveils a Hope against CORONA 2020.
[36]
Goswami T, Bagchi B. Molecular Docking study of Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein with Saikosaponin, a Triterpenoid Natural Product. ChemRxiv 2020 In press
[http://dx.doi.org/10.26434/CHEMRXIV.12033774.V1]
[37]
Fuzimoto AD, Isidoro C. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? J Tradit Complement Med 2020; 10(4): 405-19.
[http://dx.doi.org/10.1016/j.jtcme.2020.05.003] [PMID: 32691005]
[38]
Bao Y, Sun Y, Meng S, Shi J, Lancet LL-T. 2019.-nCoV epidemic: address mental health care to empower society. Lancet 2020; 395(10224)..
[39]
Pfefferbaum B, North CS. Mental Health and the Covid-19 Pandemic. N Engl J Med 2020; 383(6): 510-2.
[http://dx.doi.org/10.1056/NEJMp2008017] [PMID: 32283003]
[40]
Pedersen A, Zachariae R, Bovbjerg DH. Influence of psychological stress on upper respiratory infection-a meta-analysis of prospective studies. Psychosom Med 2010; 72(8): 823-32.
[http://dx.doi.org/10.1097/PSY.0b013e3181f1d003] [PMID: 20716708]
[41]
Shankar D, Patwardhan B. AYUSH for New India: Vision and strategy. J Ayurveda Integr Med 2017; 8(3): 137-9.
[http://dx.doi.org/10.1016/j.jaim.2017.09.001] [PMID: 28923183]
[42]
Rajkumar RP. Ayurveda and COVID-19: Where psychoneuroimmunology and the meaning response meet. Brain Behav Immun 2020; 87: 8-9.
[http://dx.doi.org/10.1016/j.bbi.2020.04.056] [PMID: 32334064]
[43]
Yang F, Zhang Y, Tariq A, Jiang X, Ahmed Z, Zhihao Z, et al. Food as medicine: A possible preventive measure against coronavirus disease (COVID-19). Phyther Res 2020.
[44]
Weber ND, Andersen DO, North JA, Murray BK, Lawson LD, Hughes BG. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med 1992; 58(5): 417-23.
[http://dx.doi.org/10.1055/s-2006-961504] [PMID: 1470664]
[45]
Ghoke SS, Sood R, Kumar N, et al. Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extracts against H9N2 virus using embryonated chicken egg model. BMC Complement Altern Med 2018; 18(1): 174.
[http://dx.doi.org/10.1186/s12906-018-2238-1] [PMID: 29866088]
[46]
Wu CY, Jan JT, Ma SH, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci USA 2004; 101(27): 10012-7.
[http://dx.doi.org/10.1073/pnas.0403596101] [PMID: 15226499]
[47]
Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 2003; 361(9374): 2045-6.
[http://dx.doi.org/10.1016/S0140-6736(03)13615-X] [PMID: 12814717]
[48]
Aboubakr HA, Nauertz A, Luong NT, et al. In vitro antiviral activity of clove and ginger aqueous extracts against feline calicivirus, a surrogate for human norovirus. J Food Prot 2016; 79(6): 1001-12.
[http://dx.doi.org/10.4315/0362-028X.JFP-15-593] [PMID: 27296605]
[49]
Sahoo M. Immunology: Current research novel heterocyclics for bomedicinal perspectives view project drug synthesis and its characterization for therapeutic effectiveness View project Immunology: Current Research 2018.
[50]
Catanzaro M, Corsini E, Rosini M, Racchi M, Lanni C. Immunomodulators inspired by nature: A review on curcumin and Echinacea. Molecules 2018; 23(11)E2778
[http://dx.doi.org/10.3390/molecules23112778] [PMID: 30373170]
[51]
Hemilä H. Vitamin C, respiratory infections and the immune system. Trends Immunol 2003; 24(11): 579-80. [1
[http://dx.doi.org/10.1016/j.it.2003.09.004] [PMID: 14596879]
[52]
Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin d supplementation could reduce risk of influenza and covid-19 infections and deaths. Nutrients 2020; 12(4)E988
[http://dx.doi.org/10.3390/nu12040988] [PMID: 32252338]
[53]
Ganjhu RK, Mudgal PP, Maity H, et al. Herbal plants and plant preparations as remedial approach for viral diseases. Virusdisease 2015; 26(4): 225-36.
[http://dx.doi.org/10.1007/s13337-015-0276-6] [PMID: 26645032]
[54]
Divya M, Vijayakumar S, Chen J, Vaseeharan B, Durán-Lara EF. A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? Microb Pathog 2020.104277
[http://dx.doi.org/10.1016/j.micpath.2020.104277] [PMID: 32473390]
[55]
Kumar VS, Navaratnam V. Neem (Azadirachta indica): prehistory to contemporary medicinal uses to humankind. Asian Pac J Trop Biomed 2013; 3(7): 505-14.
[http://dx.doi.org/10.1016/S2221-1691(13)60105-7] [PMID: 23835719]
[56]
Wen CC, Kuo YH, Jan JT, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 2007; 50(17): 4087-95.
[http://dx.doi.org/10.1021/jm070295s] [PMID: 17663539]
[57]
Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. Int J Biol Sci 2020; 16(10): 1708-17.
[http://dx.doi.org/10.7150/ijbs.45538] [PMID: 32226288]
[58]
Li SY, Chen C, Zhang HQ, et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 2005; 67(1): 18-23.
[http://dx.doi.org/10.1016/j.antiviral.2005.02.007] [PMID: 15885816]
[59]
Ferro F, Elefante E, Baldini C, et al. COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol 2020; 38(2): 175-80.
[PMID: 32207680]
[60]
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020; 39(7): 2085-94.
[http://dx.doi.org/10.1007/s10067-020-05190-5] [PMID: 32474885]
[61]
Liou CJ, Cheng CY, Yeh KW, Wu YH, Huang WC. Protective effects of casticin from Vitex trifolia alleviate eosinophilic airway inflammation and oxidative stress in a murine asthma model. Front Pharmacol 2018; 9: 635.
[http://dx.doi.org/10.3389/fphar.2018.00635] [PMID: 29962952]
[62]
Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytother Res 2008; 22(2): 141-8.
[http://dx.doi.org/10.1002/ptr.2295] [PMID: 17886224]
[63]
Lin CW, Tsai FJ, Tsai CH, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res 2005; 68(1): 36-42.
[http://dx.doi.org/10.1016/j.antiviral.2005.07.002] [PMID: 16115693]
[64]
Yang C, Lee Y, Kang I, Barnard D, Jan J. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible
[65]
Loizzo MR, Saab AM, Tundis R, et al. Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. Chem Biodivers 2008; 5(3): 461-70.
[http://dx.doi.org/10.1002/cbdv.200890045] [PMID: 18357554]
[66]
Roh C. A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide. Int J Nanomedicine 2012; 7: 2173-9.
[http://dx.doi.org/10.2147/IJN.S31379] [PMID: 22619553]
[67]
Chen C, Lin C, Huang K WC-E-B. , 2005 undefined. Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3, 3’-digallate (TF3). HindawiCom nd 2005.
[68]
Yang C, Lee Y, Hsu H, Shih C. Targeting coronaviral replication and cellular JAK2 mediated dominant NF-κB activation for comprehensive and ultimate inhibition of coronaviral activity. NatureCom nd 2017.
[69]
Ryu YB, Jeong HJ, Kim JH, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg Med Chem 2010; 18(22): 7940-7.
[http://dx.doi.org/10.1016/j.bmc.2010.09.035] [PMID: 20934345]
[70]
Ulasli M, Gurses SA, Bayraktar R, et al. The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family. Mol Biol Rep 2014; 41(3): 1703-11.
[http://dx.doi.org/10.1007/s11033-014-3019-7] [PMID: 24413991]
[71]
Lin SC, Ho CT, Chuo WH, Li S, Wang TT, Lin CC. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis 2017; 17(1): 144.
[http://dx.doi.org/10.1186/s12879-017-2253-8] [PMID: 28193191]
[72]
Dubey K, Dubey R. Computation screening of narcissoside a glycosyloxyflavone for potential novel coronavirus 2019 (COVID-19) inhibitor. Biomed J 2020; 43(4): 363-7.
[http://dx.doi.org/10.1016/j.bj.2020.05.002] [PMID: 32426388]
[73]
Liu YT, Chen HW, Lii CK, Jhuang JH, Huang CS, Li ML. A diterpenoid, 14-deoxy-11, 12-didehydroandrographolide, in andrographis paniculata reduces steatohepatitis and liver injury in mice fed a high-fat and high-cholesterol diet. Nutrients 2020; 12(2): 523.
[74]
Tsai YC, Lee CL, Yen HR, et al. Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus nl63. Biomolecules 2020; 10(3)E366
[http://dx.doi.org/10.3390/biom10030366] [PMID: 32120929]
[75]
Luo W, Su X, Gong S, Qin Y, Liu W. Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. Biosci Trends 3(4): 124-6.

Rights & Permissions Print Cite
Article Metrics
22
1
© 2024 Bentham Science Publishers | Privacy Policy